Monsanto is a multinational agricultural biotechnology company based in St. Louis, Missouri. From 1974 until the expiration of its patent in 2000, Monsanto’s Roundup® weed killer was the only glyphosate-based herbicide sold in the United States. Monsanto consistently marketed its product as safe to humans, and still maintains today that its product does not pose a health hazard. Monsanto has never warned users that Roundup® could be dangerous to their health.
Behind the scenes, Monsanto created fake data and engaged in a campaign of misinformation to combat claims that Roundup® is dangerous. In fact, documents emerged in recent litigation that demonstrate Monsanto colluded with the EPA to refute the connection between Roundup® and cancer. Even in the face of mounting scientific evidence to the contrary, Monsanto continues to vigorously deny that Roundup® can cause cancer to users.
In 2015, the International Agency for Research on Cancer (IARC) classified glyphosate, the active ingredient in Monsanto’s Roundup®, as a “probable carcinogen to humans.” IARC made this classification after years of thorough and exhaustive research and analysis, after examining peer-reviewed studies in scientific literature and analyzing occupational exposure of farmers and tree nursery workers around the world. This evidence, untainted by Monsanto’s campaign of misinformation, informed IARC’s decision to elevate glyphosate to “probable carcinogen” status.
If you or a loved one has used Monsanto’s Roundup® and developed Non-Hodgkin’s Lymphoma, Large Diffuse B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, or Cutaneous T-Cell Lymphoma you may be entitled to financial compensation. Please contact the experts at Cooney & Conway and ask about your legal rights. Call us toll free at 800-322-5573 or fill out the form below and our team will be in touch with you shortly.